In a report released on August 8, Lisa Gill from J.P. Morgan maintained a Sell rating on Owens & Minor (OMI – Research Report), with a price target of $21.00. The company’s shares closed yesterday at $20.18.
According to TipRanks, Gill is a 5-star analyst with an average return of 15.2% and a 63.77% success rate. Gill covers the Healthcare sector, focusing on stocks such as UnitedHealth, Cigna, and CVS Health.
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Owens & Minor with a $19.60 average price target, representing a -2.87% downside. In a report released on August 4, Bank of America Securities also reiterated a Sell rating on the stock with a $16.00 price target.
See the top stocks recommended by analysts >>
Based on Owens & Minor’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $2.56 billion and a GAAP net loss of $28.24 million. In comparison, last year the company earned a revenue of $2.5 billion and had a net profit of $28.6 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Owens & Minor, Inc. is a global healthcare solutions company. It integrates technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. The firm has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.
Read More on OMI:
